Expanding evidence leads to new pharmacogenomics payer coverage

被引：55

作者：

Empey, Philip E. ^{[1
]}

Pratt, Victoria M. ^{[2
]}

Hoffman, James M. ^{[3
,4
]}

Caudle, Kelly E. ^{[4
]}

Klein, Teri E. ^{[5
]}

机构：

[1] Univ Pittsburgh, Dept Pharm & Therapeut, Pittsburgh, PA 15240 USA

[2] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA

[3] St Jude Childrens Res Hosp, Off Qual & Patient Care, 332 N Lauderdale St, Memphis, TN 38105 USA

[4] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA

[5] Stanford Univ, Dept Biomed Data Sci & Med, Stanford, CA 94305 USA

来源：

关键词：

D O I：

10.1038/s41436-021-01117-w

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：830 / 832

页数：3

共 10 条

[1] The landscape of pharmacogenetic testing in a US managed care population
Anderson, Heather D.
Crooks, Kristy R.
Kao, David P.
Aquilante, Christina L.
[J]. GENETICS IN MEDICINE, 2020, 22 (07) : 1247 - 1253
[2] Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature
Berm, Elizabeth J. J.
de Looff, Margot
Wilffert, Bob
Boersma, Cornelis
Annemans, Lieven
Vegter, Stefan
van Boven, Job F. M.
Postma, Maarten J.
[J]. PLOS ONE, 2016, 11 (01):
[3] Brennan Z., 2018, FDA WARNS US MAN GEN
[4] Evidence and resources to implement pharmacogenetic knowledge for precision medicine
Caudle, Kelly E.
Gammal, Roseann S.
Whirl-Carrillo, Michelle
Hoffman, James M.
Belling, Mary V.
Klein, Teri E.
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (23) : 1977 - 1985
[5] Centers for Medicare & Medicaid Services, 2020, WHO AR MACS
[6] Hefti Erik, 2016, J AHIMA, V87, P56
[7] Kogan JN, 2018, AM J MANAG CARE, V24, P177
[8] Palmetto GBA. Local Coverage Determination (LCD), 2018, LOCAL COVERAGE DETER
[9] The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later
Relling, Mary V.
Klein, Teri E.
Gammal, Roseann S.
Whirl-Carrillo, Michelle
Hoffman, James M.
Caudle, Kelly E.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) : 171 - 175
[10] US Department of Health and Human Services, 2020, RES GUID OTH INF ISS, DOI [10.1038/s41436-021-01117-w, DOI 10.1038/S41436-021-01117-W]